This reference uses VA rating codes. For a code from a medical record, check ICD-10-CM and the service date. A clinical code alone does not establish a VA rating or a matching VA diagnostic code.
Agranulocytosis, acquired
Hemic and lymphatic · 38 CFR § 4.117
Diagnostic Code 7702 is the VASRD entry for Agranulocytosis, acquired. VA applies the controlling criteria, shared formulas, and special instructions shown in 38 CFR Part 4. VMC presents this material for education and reference; it does not determine a Veteran's diagnosis, service connection, or evaluation.
Print the source-verified reference on this page, or choose Save as PDF in your browser’s print dialog.
Source-verified VASRD criteria
How VA rates this diagnostic code
These percentages summarize the regulatory criteria already mapped to this diagnostic code. They do not predict a Veteran's individual evaluation or establish service connection.
Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period
Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl; or infections recurring, on average, at least once every three months per 12-month period
Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl; or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period
Requiring continuous medication (e.g., antibiotics) for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/µl
Regulatory notes
- Note: A 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission and shall continue with a mandatory VA examination six months following hospital discharge. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter
Body system and anatomy metadata
Body system: Hemic and lymphatic
Anatomy / region tags: hematologic
These tags support discovery and body-map compatibility. They do not establish Veteran-specific laterality or entitlement.
Official VA DBQ references
DBQ catalog: va-dbq-2026.09.16 · Retrieved 2026-09-16. Official VA inventory ↗
- Hematologic and Lymphatic Conditions, Including Leukemia ↗ Related resourceCatalog category: Hematologic & Lymphatic
Related by body system only. No reviewed condition-specific form match or requirement has been established.
VA maintains some examination forms that are not available for public use. VMC does not infer a one-code-to-one-DBQ relationship.
Evidence information
When reviewing the criteria, useful evidence categories can include diagnosis and treatment records, objective testing identified by the schedule, documented frequency/duration/severity when the criteria use those concepts, and functional effects described in medical or lay evidence. The relevant evidence depends on the actual claim and medical facts.
VMC does not diagnose conditions, guarantee a percentage, or advise anyone to exaggerate symptoms.
Legal basis and source identification
38 CFR § 4.117 · Source current through 2026-08-06 · Verified 2026-08-10
Registry content release: vasrd-registry-2026.08.1